(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 1.46% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.79%.
Icu Medical's revenue in 2024 is $2,304,277,000.On average, 2 Wall Street analysts forecast ICUI's revenue for 2024 to be $55,981,518,204, with the lowest ICUI revenue forecast at $55,885,038,352, and the highest ICUI revenue forecast at $56,077,998,056. On average, 2 Wall Street analysts forecast ICUI's revenue for 2025 to be $57,543,514,796, with the lowest ICUI revenue forecast at $56,393,084,155, and the highest ICUI revenue forecast at $58,693,945,437.
In 2026, ICUI is forecast to generate $60,479,433,332 in revenue, with the lowest revenue forecast at $60,479,433,332 and the highest revenue forecast at $60,479,433,332.